Fluvoxamine: A review of the controlled trials in depression

Journal of Clinical Psychiatry

Volumn 58, Issue SUPPL. 5, 1997, Pages 15-23

  Ware, Michael R ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; CLOMIPRAMINE; DESIPRAMINE; DOSULEPIN; FLUPENTIXOL; FLUVOXAMINE; FLUVOXAMINE MALEATE; IMIPRAMINE; MAPROTILINE; MIANSERIN; MOCLOBEMIDE; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

CONSTIPATION; DEPRESSION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; GASTROINTESTINAL SYMPTOM; HUMAN; NAUSEA; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; REVIEW; VISUAL IMPAIRMENT; XEROSTOMIA;

ANTIDEPRESSIVE AGENTS; CONTROLLED CLINICAL TRIALS; DEPRESSIVE DISORDER; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FLUVOXAMINE; HUMANS; PLACEBOS; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 0030994985     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Whitaker-Azmitia PM. The Neuropharmacology of Serotonin: Current Concepts. Kalamazoo, Mich: Upjohn Company; 1992
2. Grimsley SR, Jann MW. Paroxetine, sertraline, and fluvoxamine: new selective serotonin reuptake inhibitors. Clinical Pharmacy 1992;11:930-957
3. Claassen V, Davies JE, Hertting G, et al. Fluvoxamine, a specific 5-hydroxytryptamine uptake inhibitor. Br J Pharmacol 1977;60:505-516
4. Fuller RW, Wong DT. Serotonin reuptake blockers in vitro and in vivo. J Clin Psychopharm 1987;7:36S-43S
5. Richelson E. Pharmacology of antidepressants: characteristics of the ideal drug. Mayo Clin Proc 1994;69:1069-1081
6. Lapierre YD, Rastogi RB, Singhal RL. Fluvoxamine influences serotonergic system in the brain: neurochemical evidence. Neuropsychobiology 1983;10:213-216
7. DeVane CL. Pharmacokinetics of the newer antidepressants: clinical relevance. Am J Med 1994;97(suppl 6A):13S-23S
8. Caccia S, Garattini S. Pharmacokinetic and pharmacodynamic significance of antidepressant drug metabolites. Pharmacol Res 1992;26:317-329
9. Roos JC. Cardiac effects of antidepressant drugs: a comparison of the tricyclic antidepressants and fluvoxamine. Br J Pharmacol 1983;15:439S-445S
10. Amin MM, Ananth JV, Coleman BS, et al. Fluvoxamine: antidepressant effects confirmed in a placebo-controlled international study. Clin Neuropharmacol 1984;7(suppl 1):580-581
11. Dominguez RA, Goldstein BJ, Jacobson AF, et al. A double-blind placebo-controlled study of fluvoxamine and imipramine in depression. J Clin Psychiatry 1985;46:84-87
12. Feighner JP, Boyer WF, Meredith CH, et al. A placebo-controlled inpatient comparison of fluvoxamine maleate and imipramine in major depression. Int Clin Psychopharmacol 1989;4:239-244
13. Itil TM, Shrivastava RK, Mukherjee S, et al. A double-blind placebo-controlled study of fluvoxamine and imipramine in outpatients with primary depression. Br J Clin Pharmacol 1983;15:433S-438S
14. Lapierre YD, Browne M, Horn E, et al. Treatment of major affective disorder with fluvoxamine. J Clin Psychiatry 1987;48:65-68
15. Lydiard RB, Laird LK, Morton WA, et al. Fluvoxamine, imipramine, and placebo in the treatment of depressed outpatients: effects on depression. Psychopharmacol Bull 1989;25:68-70
16. March JS, Kobak KA, Jefferson JW, et al. A double-blind, placebo-controlled trial of fluvoxamine versus imipramine in outpatients with major depression. J Clin Psychiatry 1990;51:200-202
17. Norton KRW, Sireling LI, Bhat AV, et al. A double-blind comparison of fluvoxamine, imipramine, and placebo in depressed patients. J Affect Disord 1984;7:297-308
18. Amore M, Bellini M, Berardi D, et al. Double-blind comparison of fluvoxamine and imipramine in depressed patients. Current Therapeutic Research 1989;46:815-820
19. Bramanti P, Ricci RM, Roncari R, et al. An Italian multicenter experience with fluvoxamine, a new antidepressant drug, versus imipramine. Current Therapeutic Research 1988;43:718-724
20. Gonella G, Baignoli G, Ecari U. Fluvoxamine and imipramine in the treatment of depressive patients: a double-blind controlled study. Curr Med Res Opin 1990;12:177-184
21. Guelfi JD, Dreyfus JF, Pichot P. A double-blind controlled clinical trial comparing fluvoxamine with imipramine. Br J Clin Pharmacol 1983;15:411S-417S
22. Guy G, Wilson WH, Ban TA, et al. A double-blind clinical trial of fluvoxamine and imipramine in patients with primary depression. Psychopharmacol Bull 1984;20:73-78
23. DeWilde JEM, Doogan DP. Fluvoxamine and chlorimipramine in endogenous depression. J Affect Disord 1982;4:249-259
24. DeWilde JE, Mertens C, Wakelin JS. Clinical trials of fluvoxamine vs chlorimipramine with single and three times daily dosing. Br J Clin Pharmacol 1983;15:427S-431S
25. Dick P, Ferrero E. Double-blind comparative study of the clinical efficacy of fluvoxamine and chlorimipramine. Br J Clin Pharmacol 1983;15:419S-425S
26. Klok CJ, Brouwer GJ, VanPraag HM, et al. Fluvoxamine and clomipramine in depressed patients. Acta Psychiatr Scand 1981;64:1-11
27. Ottevanger EA. Fluvoxamine and clomipramine in depressed hospitalized patients: results from a randomized, double-blind study. L'Encéphale 1995;21:317-321
28. Harris B, Szulecka TK, Anstee JA. Fluvoxamine versus amitriptyline in depressed hospital out-patients: a multicentre double-blind comparative trial. British Journal Clinical Research 1991;2:89-99
29. Remick RA, Reesal R, Oakander M, et al. Comparison of fluvoxamine and amitriptyline in depressed outpatients. Current Therapeutic Research 1994;55:243-250
30. Mullin JM, Pandita-Gunawardena VR, Whitehead AM. A double-blind comparison of fluvoxamine and dothiepin in the treatment of major affective disorder. Br J Clin Pract 1988;42:51-55
31. Rahman MK, Akhtar MJ, Sharma RR, et al. A double-blind, randomized comparison of fluvoxamine with dothiepin in the treatment of depression in elderly patients. Br J Clin Pract 1991;45:255-258
32. Nathan RS, Perel JM, Pollock BG, et al. The role of neuropharmacologic selectivity in antidepressant action: fluvoxamine versus desipramine. J Clin Psychiatry 1990;51:367-372
33. Roth D, Mattes J, Sheehan KH, et al. A double-blind comparison of fluvoxamine, desipramine, and placebo in outpatients with depression. Prog Neuropsychopharmacol Biol Psychiatry 1990;14:929-939
34. Perez A, Ashford JJ. A double-blind, randomized comparison of fluvoxamine with mianserin in depressive illness. Curr Med Res Opin 1990;12:234-241
35. Phanjoo AL, Wonnacott S, Hodgson A. Double-blind comparative multicentre study of fluvoxamine and mianserin in the treatment of major depressive episode in elderly people. Acta Psychiatr Scand 1991;83:476-479
36. Bougerol T, Uchida C, Gachoud JP, et al. Efficacy and tolerability of moclobemide compared to fluvoxamine in depressive disorder (DSM-III). Psychopharmacology (Berl) 1992;106:S102-S108
37. Conti L, Dell'Osso L, Re F, et al. Fluvoxamine maleate: double-blind clinical trial vs placebo in hospitalized depressed patients. Current Therapeutic Research 1988;43:468-480
38. deJonghe F, Swinkels J, Tuynman-Qua H. Randomized double-blind study of fluvoxamine and maprotiline in treatment of depression. Pharmacopsychiatry 1991;24:21-27
39. Hamilton BA, Jones PG, Hoda AN, et al. Flupenthixol and fluvoxamine in mild to moderate depression: a comparison in general practice. Pharmatherapeutica 1989;5:292-297
40. Nemeroff CB, Ninan PT, Ballenger JC, et al. Safety and tolerance of fluvoxamine versus sertraline in depressed outpatients. In: New Research Program and Abstracts of the 148th Annual Meeting of the American Psychiatric Association; May 20-25, 1995; Miami, Fla. Abstract NR 455:177
41. De Vane CL. Comparative safety and tolerability of selective serotonin re-uptake inhibitors. Human Psychopharmacology 1995;10:S185-S193
42. Saletu B, Schjerve M, Grunberger J, et al. Fluvoxamine: a new serotonin reuptake inhibitor: first clinical and psychometric experience in depressed patients. Journal of Neural Transmission 1976;41:17-36